Jin Suk Kang

Dr. Jin Suk Kang

Internal Medicine, College of Medicine, Inje University, Busan, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Journal of Korean Medical Science
Verified
Journal Article
Open access
JKJin Suk Kang
Jin Suk Kang
JYJongyoun Yi
Jongyoun Yi
MKMee Kyung Ko
Mee Kyung Ko
SLSoon Ok Lee
Soon Ok Lee
SLShinwon Lee
Shinwon Lee
KKKye-Hyung Kim
Kye-Hyung Kim
Kang JS, et al. J Korean Med Sci. 2019 Apr;34(18):e140. https://doi.org/10.3346/jkms.2019.34.e140

1 January 2021 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JKJin Suk Kang
Jin Suk Kang
CMChisook Moon
Chisook Moon
SMSeok Jun Mun
Seok Jun Mun
SLShinwon Lee
Shinwon Lee
SLSoon Ok Lee
Soon Ok Lee
SLSun Hee Lee
Sun Hee Lee
Kang JS, et al. J Korean Med Sci. 2021 Sep;36(43):e273. https://doi.org/10.3346/jkms.2021.36.e273

1 January 2020 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
HSHyeon Jeong Suh
Hyeon Jeong Suh
DKDeok Hee Kim
Deok Hee Kim
EHEun Young Heo
Eun Young Heo
HLHyun Woo Lee
Hyun Woo Lee
JLJung-Kyu Lee
Jung-Kyu Lee
SPSang-Won Park
Sang-Won Park
Suh HJ, et al. J Korean Med Sci. 2020 Jul;35(32):e297. https://doi.org/10.3346/jkms.2020.35.e297

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
SLShinwon Lee
Shinwon Lee
SLSun Hee Lee
Sun Hee Lee
SLShinwon Lee
Shinwon Lee
JKJin Suk Kang
Jin Suk Kang
SLSeung-Geun Lee
Seung-Geun Lee
IKIhm Soo Kwak
Ihm Soo Kwak
Lee S, et al. J Korean Med Sci. 2017 Sep;32(9):1445-1450. https://doi.org/10.3346/jkms.2017.32.9.1445

1 January 2019 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
JKJin Suk Kang
Jin Suk Kang
SLSun Hee Lee
Sun Hee Lee
SLShinwon Lee
Shinwon Lee
Gwang Ha KimGwang Ha Kim
Gwang Ha Kim
YPYoung Joo Park
Young Joo Park
CMChisook Moon
Chisook Moon
Kang JS, et al. Infect Chemother. 2019 Mar;51(1):35-44. https://doi.org/10.3947/ic.2019.51.1.35

7 February 2024 in Viruses
Verified
Journal Article
Open access
PDF file
SLSun Hee Lee
Sun Hee Lee
SLShinwon Lee
Shinwon Lee
SLSoon Ok Lee
Soon Ok Lee
SLShinwon Lee
Shinwon Lee
WKWoo Seog Ko
Woo Seog Ko
HSHyunjin Son
Hyunjin Son
We aimed to assess the temporal trends of incident syphilis and its associated risk factors among men with HIV (Human Immunodeficiency Virus) in Korea during the COVID-19 pandemic. We conducted a retrospective cohort study of men with HIV attending an HIV clinic in Korea between 2005 and 2022. Of 767 men with HIV, 499 were included and contributed 3220 person-years (PY) of the observation period. Eighty-two patients were diagnosed with incident syphilis, with an overall incidence of 2.55/100 PY (95% confidence interval [CI] 20.56–31.53). The incidence of syphilis per 100 PY gradually decreased from 2.43 (0.79–7.42) in 2005–2007 to 1.85 (1.08–3.17) in 2014–2016; however, it increased to 3.0 (1.99–4.53) in 2017–2019, and further to 3.33 (2.26–4.89) in 2020–2022. A multivariate analysis identified young age (≤30 years versus >50, adjusted HR 6.27, 95% CI 2.38–16.56, p < 0.001), treponemal test positive at baseline (2.33, 1.48–3.67, p < 0.001), men who have sex with men (2.36, 1.34–4.16, p = 0.003), and history of incarceration (2.62, 1.21–5.67, p = 0.015) as risk factors for incident syphilis. Recently, syphilis incidence in men with HIV has increased in Korea, especially in young patients and at-risk groups, highlighting the need for enhanced regular screening and targeted behavioral interventions among these populations.